Today, Quest Diagnostics, Inc. (NYSE: DGX) Takes Center Stage

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Most recently, Yahoo Finance reported about the stock as it publicized that She Is Not Skipping a Beat, and Patients Are Noticing.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

The company is listed on the NYSE and operates within the Diagnostics & Research industry segment. The current market capitalization of Quest Diagnostics, Inc. is $14.74B. A total of 0.89 million shares were traded on the day, compared to an average of 1.04M shares.

In the most recent transaction, PREVOZNIK MICHAEL E sold 5,611 shares of DGX for 125.88 per share on Feb 29 ’24. After the transaction, the SVP & General Counsel now owns 38,478 company shares. In a previous transaction on Feb 29 ’24, Doherty Catherine T. sold 1,187 shares at 125.88 per share. DGX shares that EVP, Regional Businesses owns now total 68,412.

Among the insiders who sold shares, Doherty Catherine T. disposed of 5,557 shares on Feb 28 ’24 at a per-share price of $126.57. This resulted in the EVP, Regional Businesses holding 69,599 shares of DGX after the transaction. In another insider transaction, Gregg Vicky B sold 2,500 shares at $126.64 per share on Feb 23 ’24. Company shares held by the Director now total 16,329.


The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. Quest Diagnostics, Inc. pays an annual dividend of $2.84, resulting in a dividend yield of 2.13%, and it has a price to earnings (P/E) ratio of 17.78. DGX’s most recent ex-dividend date was 4/5/2024 when it declared a $0.75 quarterly dividend that was paid in cash on 4/22/2024. Previously, the company paid the dividend on 1/31/2024 with an ex-dividend date of 1/16/2024. The DGX stock dividend was $0.71 per share in cash.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, DGX has a high of $148.62 and a low of $119.59.

As of this writing, DGX has an earnings estimate of $1.85 per share for the current quarter. EPS was calculated based on a consensus of 15 estimates, with a high estimate of $1.9 per share and a lower estimate of $1.8. The company reported an EPS of $2.22 in the last quarter, which was 1.40% higher than expectations of $2.19.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. DGX’s latest balance sheet shows that the firm has $872.00M in Cash & Short Term Investments as of fiscal 2021. There were $4.77B in debt and $1.75B in liabilities at the time. Its Book Value Per Share was $56.82, while its Total Shareholder’s Equity was $6.56B.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DGX is Buy with a score of 3.53.

Most Popular

Related Posts